Here's Why You Should Hold HUN Stock in Your Portfolio Now
Source: Nasdaq

Huntsman’s Q2 2026 Polyurethanes revenue rose 16% year over year and adjusted EBITDA more than doubled to $66 million, while Advanced Materials revenue increased 19% and EBITDA climbed 42%. Management guided Q3 adjusted EBITDA to $100-$130 million, supported by pricing actions, downstream expansion and more than $50 million of 2026 cost-savings benefits. The pending all-stock Olin merger, targeted to close in H1 2027, could generate more than $400 million of synergies and roughly $125 million of cash tax benefits, but weak construction demand, tariff uncertainty and volatile benzene and European gas costs temper the outlook.
Analysis
HUN’s equity case is transitioning from a pure-cycle recovery to an execution story: downstream mix and fixed-cost removal raise incremental EBITDA conversion, but only if price/cost spreads hold. The key sensitivity is not headline MDI pricing but the lag between feedstock and energy inflation and contractual price recovery; a renewed European gas spike could temporarily erase the benefit of higher nominal selling prices. Over the next 1-3 months, the relevant catalyst is whether quarterly EBITDA lands above the midpoint of management’s range without further working-capital consumption.
The proposed combination creates a more asymmetric setup for OLN than HUN if closing probability rises. Olin contributes feedstock and chlor-alkali cyclicality while HUN contributes specialty end markets, so synergy realization could reduce earnings volatility and support a higher through-cycle multiple for the combined entity; however, integration is complicated by very different customer bases and chemical-cycle exposures. Regulatory clearance remains a binary risk through 1H27, and the absence of disclosed exchange-ratio economics in the supplied information prevents a disciplined merger-arbitrage recommendation.
Consensus may be too focused on construction as the gating variable. HUN can improve earnings before a broad construction rebound if industrial, aerospace, power and automotive mix remains favorable and capacity rationalization tightens regional MDI balances. Conversely, this is not yet a clean long: China-led price weakness, tariff-driven customer destocking, or a failure of announced price increases to cover benzene/natural-gas inflation would expose the stock’s still-cyclical earnings base and likely compress the recovery multiple.
For the 6-18 month horizon, specialty-formulation competitors with less upstream exposure—such as IOSP—offer cleaner margin durability, while WS is a more direct domestic industrial-recovery vehicle with less European energy sensitivity. HUN’s relative underperformance can reverse only if management demonstrates that higher-margin acquired businesses are producing sustained cash earnings rather than merely lifting reported mix during a favorable pricing window.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mixed
Sentiment Score
0.12
Ticker Sentiment
Key Decisions for Investors
- Maintain HUN as a watchlist long rather than add aggressively before the next earnings release; upgrade only if EBITDA exceeds the top end of guidance while net working capital is flat-to-down and price/cost recovery is sustained. Falsify on a guidance cut tied to Europe or China, or evidence that incremental margins are declining despite sales growth.
- Prefer a 3-6 month pair trade long IOSP / short HUN for defensive chemicals exposure if European gas and benzene remain elevated: IOSP’s specialty-heavy model should be less exposed to commodity spread compression. Reassess if HUN demonstrates two consecutive quarters of downstream-margin expansion or if industrial demand broadens materially.
- Track OLN/HUN implied deal spread once the exchange ratio, termination provisions and remaining approval timetable are available; initiate merger arbitrage only when the annualized spread compensates for a potential 1H27 close and chemical-cycle beta. Do not treat HSR expiration alone as sufficient closing certainty.
- Use WS rather than HUN for a tactical 1-3 month long if U.S. construction/industrial indicators inflect upward, since its earnings sensitivity is more directly tied to domestic steel demand. Exit the relative preference if tariff escalation materially disrupts North American automotive production or if housing data deteriorate further.
More News
- This AI-picked stock jumps 18% on Amazon’s $8 billion power deal
- Crusoe raises $3.9B to build massive data centers and small modular “AI factories”
- Jensen Huang says Nvidia will sell twice as many chips next year
- Generac shares surge on big Amazon deal. Wall Street thinks the generator stock has more to go
- Warsh spooks investors, OpenAI's 'concerning' incidents, Boeing's production problems and more in Morning Squawk
- Goldman’s top strategist just added hard numbers to his earnings-bubble warning